VASO Corp Appoints Shaun McMeans to Board

What Happened
VASO Corp announced on July 23, 2026 that Shaun McMeans (age 64) was appointed as a Class III director, effective immediately. Mr. McMeans currently serves as Chief Financial Officer of Nabsys and was CFO of HTG Molecular Diagnostics from 2012–2023. He will join VASO’s audit committee and is designated as a financial expert.

Key Details

• Appointment effective: July 23, 2026; position: Class III director.
• Committee role & qualification: Member of the Board’s audit committee; qualifies as a financial expert.
• Compensation: Entitled to a pro‑rated portion of non‑employee director pay and a one‑time new director grant of 100,000 shares of VASO common stock.
• Independence/related‑party: No family relationships, reportable related‑party transactions, or special arrangements tied to the appointment.

Why It Matters
Adding a seasoned finance executive and a designated financial expert to the audit committee can strengthen oversight of VASO’s financial reporting and controls—an important governance signal for investors. The one‑time grant of 100,000 shares represents a compensation cost (and potential dilution) for shareholders, though the filing discloses no other related‑party issues or special inducements tied to the appointment.